Seven strains of Roseburia sp., Faecalibacterium prausnitzii, and Coprococcus sp. from the human gut that produce high levels of butyric acid in vitro were studied with respect to key butyrate pathway enzymes and fermentation patterns. Strains of Roseburia sp. and F. prausnitzii possessed butyryl coenzyme A (CoA):acetateCoA transferase and acetate kinase activities, but butyrate kinase activity was not detectable either in growing or in stationary-phase cultures. Although unable to use acetate as a sole source of energy, these strains showed net utilization of acetate during growth on glucose. In contrast, Coprococcus sp. strain L2-50 is a net producer of acetate and possessed detectable butyrate kinase, acetate kinase, and butyryl-CoA:acetate-CoA transferase activities. These results demonstrate that different functionally distinct groups of butyrate-producing bacteria are present in the human large intestine.
There is currently much interest in optimizing the healthprotective activities of the colonic microflora and in preventing gastrointestinal disorders through control of the diet (4, 15, 16, 17) . The anaerobic microbial communities of the gut are exceedingly complex, however, being characterized by high cell densities and strain diversity and a significant degree of interspecies cross-feeding and microbial interaction (9) . Recent molecular studies have demonstrated that up to 75% of the 16S ribosomal DNA (rDNA) sequence diversity is apparently unrelated to known bacterial species (13, 25) . The challenge now must be to identify and culture new bacterial species that contribute to key aspects of anaerobic metabolism in the gut.
The main products of microbial fermentation in the large intestine can vary significantly in their relative concentrations and production rates depending on diet and site of production (27, 28) , with typical ratios in feces being around 3:1:1 acetatepropionate-butyrate (6, 7) . Butyrate has a particularly important role as the preferred energy source for the colonic epithelium and a proposed role in providing protection against colon cancer and colitis (1, 4, 5) . Butyrate can reduce gut mucosal inflammation by inhibiting the activity of the transcription factor NF-B, which in turn mediates the effects of proinflammatory cytokines (14) . Barcenilla et al. (2) recently isolated a range of butyrate-producing strains from human feces. Most (Ͼ80%) of the strains that produced high concentrations (Ͼ10 mM) of butyrate in batch culture in vitro have now been identified by 16S rDNA sequencing and phenotypic tests as species of the gram-positive anaerobes Roseburia (10) and Faecalibacterium (previously Fusobacterium) (11) . Many of the Roseburia isolates (Table 1) were found to belong to a new species, Roseburia intestinalis (10) . Nothing is currently known about the enzymology or physiology of butyrate production by any of these species.
Butyrate is normally formed from two molecules of acetyl coenzyme A (CoA), yielding acetoacetyl-CoA, which is then converted to butyryl-CoA (reviewed in reference 8). Thereafter, butyryl-CoA may yield butyrate via butyrate kinase, as in some strains of ruminal Butyrivibrio fibrisolvens (8) or via butyryl-CoA:acetate-CoA transferase (Fig. 1) . In the latter reaction butyryl-CoA is exchanged with exogenously derived acetate to yield acetyl-CoA and butyrate. Diez-Gonzalez et al. (8) suggested the existence of two distinct metabolic types, differing in acetate utilization and lactate formation, among butyrate-producing B. fibrisolvens strains from the rumen, apparently correlating with the possession of either butyrate kinase or butyryl-CoA:acetate-CoA transferase. Here we report metabolic and enzymological studies of strains belonging to four species of butyrate-producing bacteria from human feces, Coprococcus sp., Roseburia sp., R. intestinalis, and Faecalibacterium prausnitzii.
Butyrate-producing isolates. The seven strains studied are human fecal isolates that were found to produce at least 10 mM butyrate in vitro on first isolation (2) . Based on 16S rDNA sequences and phenotypic tests, strains L1-82, L1-952, and L1-8151 belong to the newly defined species R. intestinalis (10) . Strains A2-181 and A2-183 appear to belong to another new species, not yet named, that is 95% related in rDNA sequence to Roseburia cecicola and will be referred to here as Roseburia sp. Strain L2-50 is a representative of Coprococcus sp. (2) , and strain A2-165 belongs to the new genus Faecalibacterium (previously Fusobacterium) prausnitzii (11) .
Growth requirements and media. The strains studied here were originally isolated from anaerobic roll tubes with M2GSC (20) medium containing 30% clarified rumen fluid, as described by Barcenilla et al. (2) . All seven strains were, however, able to grow in yeast extract-Casitone-fatty acids (YCFA) medium lacking rumen fluid provided that a mixture of sources of carbon and fatty acids (SCFA) (giving final concentrations of 33 mM acetate, 9 mM propionate, 1.2 mM iso-butyrate, 1.0 mM iso-valerate, and 1.0 mM valerate) was added ( with glucose at 10 mM) ( Table 2 ). All the strains produced butyrate, various amounts of formate, and relatively small amounts of lactate. The level of production of butyrate in these experiments was slightly lower, especially for Coprococcus sp. strain L2-50, than that previously reported for the same strains when they were grown on the rumen fluid containing M2GSC medium (2) . In order to estimate carbon and electron recoveries, we performed additional experiments in which the medium was prepared and maintained under O 2 -free N 2 in place of CO 2 and NaHCO 3 was omitted. In order to avoid possible contributions from energy sources other than glucose, Casitone was omitted and the concentration of yeast extract was reduced to 0.2% (wt/vol) (medium YFAG). F. prausnitzii A2-165, however, was found to require yeast extract and Casitone, and this strain was therefore grown on YCFAG. Carbon and electron recoveries were calculated with reference to appropriate control cultures lacking glucose. Acid production was determined by capillary gas chromatography (GC) following conversion to t-butyldimethylsilyl derivatives (22) . H 2 production was analyzed by packed-column GC (24) . Carbon dioxide production was determined in these experiments by isotope dilution. Three replicate 24-h incubations were stopped by the addition of 1 ml of concentrated orthophosphoric acid through a gastight septum. One tube of each pair was used to determine the natural abundance of the CO 2 , and to the other tube 100 l of 2.5 mM NaH 13 CO 3 (98 atom%; Isotec Inc., Miamisburg, Ohio) was added by injection. All tubes were then shaken at 100°C for 15 min, and then 0.5 ml of the hot headspace gas was removed into a gas-tight syringe and injected into a continuous-flow gas isotope mass spectrometer (Tracermass 20-20; Europa Scientific, Crewe, Cheshire, United Kingdom). From the increase in enrichment (from ion intensities at m/z 44 and 45) above natural abundance and the amount of NaH 13 CO 3 added, the total amount of CO 2 in the tube was calculated. The amount of CO 2 obtained in the uninoculated medium was subtracted to yield the quantity of CO 2 produced. Theoretical CO 2 values calculated according to the method discussed in reference 29 were in general higher than the measured values (Table 3) .
Carbon recoveries were determined using the theoretical CO 2 values, as the direct measurements appear likely to be underestimated due to incomplete recovery of CO 2 in the growth medium. On this basis, carbon recoveries ranged from 94 to 102% (Table 3) . Strains were screened for ethanol and butanol production by GC, but no traces of these products were found. The electron balance for F. prausnitzii A2-165, which gave the lowest carbon recoveries and which did not produce H 2 , suggested that the products were comparatively oxidized (85.4%). Whether or not the fermentation by these bacteria was accompanied by changes in the redox balance of the (highly reduced) medium was not examined.
Strain distribution of key butyrate synthetic activities. For the determination of butyrate pathway enzymes, strains were grown on M2GSC medium (80 ml) for 6 to 8 h (mid-exponential phase) and for 20 h (stationary phase) and the bacterial cell pellets were harvested by centrifugation (10,000 ϫ g for 10 min) at 4°C. The cells were washed in 50 mM phosphate buffer containing 0.05% cysteine-HCl, centrifuged as described above, and resuspended in 4 ml of the same buffer. The cells were disrupted by sonication (MSE Soniprep setting 150 for 3 min). The disrupted cells were centrifuged at 10,000 ϫ g for 5 min, and the cell debris was discarded; the extracts were used for determination of enzyme activities. Acetate kinase and butyrate kinase activities were determined by a colorimetric assay (23) . Butyryl-CoA:acetate-CoA transferase activity was measured by the method of Barker et al. (3) . The protein contents of the extracts were measured after boiling the extracts in alkali (18) .
Significant butyrate kinase activity was detected in only one of the seven strains (Coprococcus sp. strain L2-50) ( Table 4) . Butyryl-CoA:acetate-CoA transferase activity, however, was detected in all seven strains in both the exponential and stationary phase, demonstrating that this is a potentially important route for butyrate synthesis among human fecal isolates. Coprococcus sp. strain L2-50 possessed the highest butyrylCoA:acetate-CoA transferase activity in exponentially growing cells. Activities for this enzyme were 2.5-to 12-fold higher in exponential-than in stationary-phase cells in six of the seven strains, the exception being F. prausnitzii A2-165, for which activities were similar at the two growth stages.
Conclusions. The butyrate-producing strains studied here represent four distinct species of gram-positive anaerobes that belong to the Clostridium coccoides (Roseburia sp., Coprococcus sp.) and Clostridium leptum (F. prausnitzii) clusters of gram-positive bacteria. Bacteria belonging to these clusters are dominant members of the human intestinal flora, but they are frequently underrepresented among cultured isolates (12, 25, 29) . F. prausnitzii may represent up to 15% of the human fecal microflora (26) . Although first recovered using a complex rumen fluid-based medium (2), all four species can be grown on simpler rumen fluid-free media supplemented with short-chain fatty acids. F. prausnitzii shows a strong requirement for acetate, and Coprococcus sp. strain L2-50 apparently requires an SCFA other than acetate for growth. The difficulty in cultivating many human gut anaerobes may therefore often be overcome simply through supplying essential nutrients that are normally available by cross-feeding from other bacteria in the complex ecosystem in vivo.
Little work has been done previously on the enzymes that contribute to butyrate synthesis in commensal bacteria from the human colon. Butyrate kinase was detected here in only one strain, Coprococcus sp. strain L2-50. On the other hand, butyryl-CoA:acetate-CoA transferase activity was detected in all seven isolates studied here and thus provides the only known route for butyrate synthesis in the Roseburia sp. and F. prausnitzii strains.
These findings reveal a clear metabolic difference between the species studied. Roseburia sp. and F. prausnitzii strains show net acetate utilization and possess butyryl-CoA:acetateCoA transferase but apparently lack butyrate kinase. On the other hand, Coprococcus sp. strain L2-50 produces acetate and possesses both butyrate kinase and butyryl-CoA transferase. At this stage we cannot say whether the net consumption or (8) showed that increasing the acetate concentration favored butyrate production and shifted product ratios. It will be of interest to establish whether or not this effect occurs also in F. prausnitzii and Roseburia sp. From the still-limited evidence available, it appears that F. prausnitzii, Roseburia sp., and related strains may account for a significant proportion of the more active butyrate-producing strains in the human colon (2, 13, 26) . If so, we would predict that much of the butyrate carbon may be generated from acetate through the CoA transferase route in vivo, consistent with the findings of Miller and Wolin (19) . It has also been suggested that utilization by butyrate producers of lactate produced by other species, such as bifidobacteria and lactobacilli, might be significant in vivo (15) . None of the strains studied here were able to utilize lactate as a sole carbon and energy source, but we have not excluded the possibility that lactate can be utilized by strains growing on carbohydrates.
Given the current interest in dietary approaches for stimulating butyrate synthesis, especially in the distal large intestine, it is vital to understand the microbiology associated with butyrate synthesis and the relationships between substrate supply and product formation. Further work on metabolite flow in vivo and on the prevalence of Roseburia sp., Coprococcus sp., and F. prausnitzii strains, in particular, in different individuals and in response to diet appears desirable.
